Rathe, Susan K.
Moriarity, Branden S.
Stoltenberg, Christopher B.
Kurata, Morito
Aumann, Natalie K.
Rahrmann, Eric P.
Bailey, Natashay J.
Melrose, Ellen G.
Beckmann, Dominic A.
Liska, Chase R.
Largaespada, David A.
Article History
Received: 24 April 2014
Accepted: 23 July 2014
First Online: 13 August 2014
Competing interests
: Yes there is potential Competing Interest. Dr. Largaespada is co-owner and advisor to NeoClone Biotechnology, Inc. and Discovery Genomics, Inc. No resources or personnel from either company were involved in this research in any way. The remaining authors declare no competing financial interest.